Filtered By:
Condition: Asthma
Management: Expenditures

This page shows you your search results in order of date.

Order by Relevance | Date

Total 82 results found since Jan 2013.

The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma
Extract Asthma and obesity are prevalent disorders with significant impact on public health. Obesity is a reported risk factor for the development of asthma and is associated with increased exacerbation rates, medication usage and higher symptoms scores in patients with asthma. It should therefore be addressed and treated as an important asthma related comorbidity [1]. Oral corticosteroids (OCS) are widely prescribed for asthma exacerbations and for chronic management of severe asthma despite well-known adverse side-effects, including weight gain. Biologic therapies for severe asthma reduce exacerbation rates and the anti-...
Source: European Respiratory Journal - August 3, 2023 Category: Respiratory Medicine Authors: Nanzer, A. M., Taylor, V., Hearn, A. P., Kavanagh, J. E., Patrick, T., Green, L., Thomson, L., Lam, J., Fernandes, M., Roxas, C., d'Ancona, G., Kent, B. D., Dhariwal, J., Jackson, D. J. Tags: Asthma and allergy Research Letters Source Type: research

Cost-Related Medication Nonadherence In U.S. Adults With Asthma: The National Health Interview Survey 2013 –2020
: Asthma is a chronic disease that needs long-term control for secondary prevention. Health-related expenditures resulting from asthma are rising in the U.S., and medication nonadherence is associated with adverse health outcomes in patients with asthma.
Source: Annals of Allergy, Asthma and Immunology - July 24, 2023 Category: Allergy & Immunology Authors: Tong Xia, Hongbin Qiu, Bo Yu, Jinfeng Bi, Xia Gu, Shanjie Wang, Yiying Zhang Tags: Original Article Source Type: research

Cost –related medication nonadherence in US adults with asthma
Asthma is a chronic disease that needs long-term control for secondary prevention. Health-related expenditures resulting from asthma are rising in the United States, and medication nonadherence is associated with adverse health outcomes in patients with asthma.
Source: Annals of Allergy, Asthma and Immunology - July 24, 2023 Category: Allergy & Immunology Authors: Tong Xia, Hongbin Qiu, Bo Yu, Jinfeng Bi, Xia Gu, Shanjie Wang, Yiying Zhang Source Type: research

Randomized Double Blind Pilot Study of Universal, Species Abundant, Multi-Allergen Subcutaneous Immunotherapy for Moderate-Severe Allergic Rhinitis
Allergic rhinitis affects approximately 10-20% of people living in industrialized nations leading to significant morbidity and large health care expenditures. Individualized high-dose, single species allergen immunotherapy has been shown to be effective in treating allergic rhinitis but can be associated with significant risks including anaphylaxis. Few studies have examined the safety and efficacy of universal low-dose multi-allergen immunotherapy.
Source: Annals of Allergy, Asthma and Immunology - March 27, 2023 Category: Allergy & Immunology Authors: Jody Tversky, Pooja Patel, Mudiaga Sowho, Rakesh Natarajan, Tae Chung, Andrew Whelton, Antoine Azar Source Type: research

Randomized double-blind pilot study of universal, species abundant, multiallergen subcutaneous immunotherapy for moderate-severe allergic rhinitis
Allergic rhinitis affects approximately 10% to 20% of people living in industrialized nations leading to significant morbidity and large health care expenditures. Individualized high-dose, single-species allergen immunotherapy has been found to be effective in treating allergic rhinitis but can be associated with significant risks including anaphylaxis. Few studies have evaluated the safety and efficacy of universal low-dose multiallergen immunotherapy (MAIT).
Source: Annals of Allergy, Asthma and Immunology - March 27, 2023 Category: Allergy & Immunology Authors: Jody Tversky, Pooja Patel, Mudiaga Sowho, Rakesh Natarajan, Tae Chung, Andrew Whelton, Antoine Azar Tags: Original Article Source Type: research

Management of Elderly Asthma: Key Questions and Tentative Answers
Allergy Asthma Immunol Res. 2023 Jan;15(1):8-18. doi: 10.4168/aair.2023.15.1.8.ABSTRACTThe aging lung undergoes structural changes, immunosenescence, and inflammation, rendering the elderly more susceptible to developing obstructive airway disease. Thus, asthma in those of chronological age ≥ 65 years is not rare. Elderly asthma (EA) imposes considerable burdens in terms of mortality and morbidity, and expenditure. However, clinicians lack knowledge of EA and thus often prescribe inappropriate management. In this review, we ask 3 key questions frequently encountered during EA diagnosis and treatment: 1) Is EA different?;...
Source: Allergy, Asthma and Immunology Research - January 24, 2023 Category: Allergy & Immunology Authors: Heung-Woo Park Sang Heon Cho Source Type: research